Sherman Jeffrey Scott
- SEC CIK
- 0001463145
No open-market purchases or sales filed in the past year.
Current role at each company
- NEO Neogenomics IncChief Financial Officeras of Feb 24, 2026
- PRVA Privia Health Group, Inc.EVP, CFO and CAOas of Jan 7, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Sherman Jeffrey Scott as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NEO Neogenomics Inc
Chief Financial Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 6, 2025 (view filing) | Aug 6 | Same day | Sherman Jeffrey ScottChief Financial Officer | PPurchase | +20.0K | $5.62 | +$112.4K | +11.9%188.3K after | |
| May 6, 2025 (view filing) | May 2 | 4 days | Sherman Jeffrey ScottChief Financial Officer | PPurchase | +20.0K | $7.51 | +$150.2K | +14.4%158.5K after |